kanamycin injection solution
fresenius kabi usa, llc - kanamycin a sulfate (unii: j80ex28smq) (kanamycin a - unii:eqk9q303c5) - kanamycin a 333 mg in 1 ml
kanamycin-pos 6.2mg/ml eye drops solution
ursapharm arzeneitmittel gmbh industriestrasse, 66129 saarbrucken, germany - kanamycin monosulphate - eye drops - kanamycin monosulphate 6.2 mg/ml - ophthalmologicals
kanamycin-pos 6.2mg/g eye ointment
ursapharm arzeneitmittel gmbh industriestrasse, 66129 saarbrucken, germany - kanamycin monosulphate - eye ointment - kanamycin monosulphate 6.2 mg/g - ophthalmologicals
kanamycin capsules 250mg "meiji" (カナマイシンカプセル250mg「明治」)
meiji seika pharma co., ltd. - kanamycin monosulfate - pale yellow capsule, major axis: 19.4 mm, thickness: 6.9 mm
x- kanamycin sulfate powder
ax pharmaceutical corp - kanamycin sulfates (unii: ow1n4g4r9w) (kanamycin - unii:ruc37xup2p) - kanamycin 4.95 kg in 5 kg
natacyn (natamycin 5%) ophthalmic suspension
link healthcare sdn. bhd. - natamycin -
natacyn (natamycin 5%) ophthalmic suspension
link healthcare sdn. bhd. - natamycin -
kanamycin 1g biotech
biotech laboratories (pty) ltd - kanamycin sulphate - injection - each vial contains; kanamycin sulphate equivalent to kanamycin 1,000.0 mg
natacyn® (natamycin ophthalmic suspension) 5% sterile
alcon laboratories, inc. - natamycin (unii: 8o0c852cpo) (natamycin - unii:8o0c852cpo) - natacyn® (natamycin ophthalmic suspension) 5% is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including fusarium solani keratitis. as in other forms of suppurative keratitis, initial and sustained therapy of fungal keratitis should be determined by the clinical diagnosis, laboratory diagnosis by smear and culture of corneal scrapings and drug response. whenever possible the in vitro activity of natamycin against the responsible fungus should be determined. the effectiveness of natamycin as a single agent in fungal endophthalmitis has not been established. natacyn® (natamycin ophthalmic suspension) 5% is contraindicated in individuals with a history of hypersensitivity to any of its components. safety and effectiveness in pediatric patients have not been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.
natamycin 5% eye drops preservative free
special order - natamycin - eye drops - 50mg/1ml